Author: Greg Winterton

Gokul Sudarsana, Chief Investment Officer of HSCM’s Life strategy and Co-Chief Investment Officer of the Firm’s Re/Insurance strategy.

March delivered not one, not two, but three notable announcements relating to life insurer credit risk which could have an impact the life settlement market.

Those still trying to understand any potential future impact of Covid-19 on mortality are conducting an exercise in futility.

Aggregate deal value in the Canadian pension risk transfer (PRT) market set a new record in 2024 and market fundamentals suggest activity will remain strong going forward.

Martin Kramer, Managing Partner at Ceptar Consulting, shares what’s been happening in the tertiary part of the life settlement world for this month’s Q&A.

Potential new entrants seeking to get a piece of the life insurance-based permanent capital action have a few options.

The transaction, completed back in January 2025, secures the benefits of all 705 Scheme members which comprises 396 pensioners and dependants as well as 309 deferred members.

The funding ratio and the aggregate funding position of the 4,969 schemes in the PPF 7800 Index fell in March, down from 126.1% to 124.7% and a £232.7bn surplus to a £215.5bn surplus, respectively.

Universal life insurance policy application activity was yet again lower in March when compared to the prior year, seeing an 8.7% reduction compared to 2023.

The transaction involves approximately 8,200 participants and invested pension capital of around EUR 950m, making this transaction the largest buyout by Zwitserleven to date.